MSS51

Across TCGA pan-cancer cohorts, MSS51 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MSS51’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MSS51 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MSS51 is over-expressed in tumor, although a few such as BRCA and KICH show the opposite, repressed pattern.

LIHC, CHOL, and KIRC are the cancer types where MSS51 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MSS51 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	II,III,IV	+0.565	<.001	9	view →
CHOL	All	All	+1.524	<.001	5	view →
KIRC	All	All	+0.170	.001	5	view →
BRCA	Female	All	−0.311	<.001	4	view →
KICH	All	All	−0.333	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MSS51–LIHC

Open the LIHC breakdown →